ArticleThe Journal of clinical investigation2022

Favorable vaccine-induced SARS-CoV-2-specific T cell response profile in patients undergoing immune-modifying therapies.

Martin Qui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.